Osaka, Japan

Kuniko Urashima

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sumitomo Dainippon Pharma Co., Ltd.. Active years: 2017-2019.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kuniko Urashima: Innovator in Medical Chemistry

Introduction

Kuniko Urashima is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medical chemistry, particularly in the development of novel compounds for treating various pain-related conditions. With a total of 2 patents, her work is recognized for its potential impact on healthcare.

Latest Patents

Urashima's latest patents focus on benzimidazole compounds and their medical uses. These inventions provide a medicament for treating diseases involving Nav 1.7, which include neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis. The compounds are designed to offer therapeutic benefits through specific chemical formulations.

Career Highlights

Kuniko Urashima is currently associated with Sumitomo Dainippon Pharma Co., Ltd., where she continues to advance her research and development efforts. Her innovative approach to medical chemistry has positioned her as a key figure in her field.

Collaborations

Throughout her career, Urashima has collaborated with notable colleagues, including Masafumi Komiya and Keiji Adachi. These partnerships have fostered a collaborative environment that enhances the development of new medical solutions.

Conclusion

Kuniko Urashima's contributions to medical chemistry through her innovative patents highlight her role as a leading inventor in the field. Her work promises to improve treatment options for patients suffering from various pain conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…